DIFTAVAX

This brand name is authorized in Estonia, Spain, Croatia, South Africa

Active ingredients

The drug DIFTAVAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Diphtheria toxoid purified UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE

Read about Diphtheria toxoid

2 Tetanus toxoid purified UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)

Read about Tetanus toxoid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AM51	Tetanus toxoid, combinations with diphtheria toxoid	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AM Tetanus vaccines
Discover more medicines within J07AM51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1717578
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61025
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-126128199
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/30.1/0128